China Phenazone (Antipyrine) Industry Market Research Report 2023-2029

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report elaborates on the current development of the Phenazone (Antipyrine) industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)

    • Guangdong Nanguo Pharmaceutical

    • Henan Furen Huaiqingtang Pharmaceutical

    • Bayer

    • Shanxi Taiyuan Pharmaceutical

    • Wuhan Fuxing Biopharmaceutical

    • Hainan Pharmaceutical Factory

    • Guangdong Sancai Shiqi District Pharmaceutical

    • CSPC

    • Northeast Pharmaceutical

    • Kaifeng Pharmaceutical Group

    • Shandong Fangming Pharmaceutical Group

    • NCPC

    • Shandong Huaxin Pharmaceutical Group

    • Pfizer

    • Shandong Xinhua Pharmaceutical

    • Yuekang Pharmaceutical Group Anhui Biopharmaceutical

    • Endo

    • Herbages Naturbec

    • Sinopharm

    • Henan Runhong Pharmaceutical

    • Tianjin Jinyao Pharmaceutical

    • Xinxiang Changle Pharmaceutical

    By Type:

    • Liquid

    • Solution

    By Application:

    • Analytical Reagent for Nitric Acid

    • Antipyretic And Analgesic

    • Nitrite and Iodine

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Phenazone (Antipyrine) Market Overview 2018-2029

    • 1.1 China Phenazone (Antipyrine) Industry Development Overview

    • 1.2 China Phenazone (Antipyrine) Industry Development History

    • 1.3 China Phenazone (Antipyrine) Industry Market Size (2018-2029)

    • 1.4 China Phenazone (Antipyrine) Market Analysis by Type from Production Side

      • 1.4.1 China Phenazone (Antipyrine) Production Volume, Production Value and Growth Rate of Liquid (2018-2029)

      • 1.4.2 China Phenazone (Antipyrine) Production Volume, Production Value and Growth Rate of Solution (2018-2029)

    • 1.5 China Phenazone (Antipyrine) Market Analysis by Application from Consumption End

      • 1.5.1 China Phenazone (Antipyrine) Sales Volume, Sales Value and Growth Rate of Analytical Reagent for Nitric Acid (2018-2029)

      • 1.5.2 China Phenazone (Antipyrine) Sales Volume, Sales Value and Growth Rate of Antipyretic And Analgesic (2018-2029)

      • 1.5.3 China Phenazone (Antipyrine) Sales Volume, Sales Value and Growth Rate of Nitrite and Iodine (2018-2029)

    • 1.6 China Phenazone (Antipyrine) Market Analysis by Region

      • 1.6.1 North China Phenazone (Antipyrine) Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Phenazone (Antipyrine) Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Phenazone (Antipyrine) Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Phenazone (Antipyrine) Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Phenazone (Antipyrine) Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Phenazone (Antipyrine) Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Phenazone (Antipyrine) Market Size and Growth Rate from 2018-2029

    Chapter 2 China Phenazone (Antipyrine) Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Phenazone (Antipyrine) Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Phenazone (Antipyrine) Market Status and Competition Analysis in 2023

      • 2.2.3 China Phenazone (Antipyrine) Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Phenazone (Antipyrine) Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Phenazone (Antipyrine) Industry Development

    Chapter 3 Phenazone (Antipyrine)Industry Chain Analysis

    • 3.1 Phenazone (Antipyrine) Industry Chain

    • 3.2 Phenazone (Antipyrine) Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Phenazone (Antipyrine) Market

    • 3.3 Phenazone (Antipyrine) Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Phenazone (Antipyrine) Market

    Chapter 4 China Phenazone (Antipyrine) Market, by Type

    • 4.1 China Phenazone (Antipyrine) Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Phenazone (Antipyrine) Total Production Volume and Growth Rate from Production Side

    • 4.5 China Phenazone (Antipyrine) Production Volume and Growth Rate, by Type

      • 4.5.1 China Phenazone (Antipyrine) Production Volume and Growth Rate of Liquid

      • 4.5.2 China Phenazone (Antipyrine) Production Volume and Growth Rate of Solution

    Chapter 5 China Phenazone (Antipyrine) Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Phenazone (Antipyrine) Total Market Size and Growth Rate from Consumption End

    • 5.5 China Phenazone (Antipyrine) Market Size and Growth Rate, by Application

      • 5.5.1 China Phenazone (Antipyrine) Market Size and Growth Rate of Analytical Reagent for Nitric Acid

      • 5.5.2 China Phenazone (Antipyrine) Market Size and Growth Rate of Antipyretic And Analgesic

      • 5.5.3 China Phenazone (Antipyrine) Market Size and Growth Rate of Nitrite and Iodine

    Chapter 6 China Phenazone (Antipyrine) Market, by Region

    • 6.1 China Phenazone (Antipyrine) Production Volume and Production Value, by Region

    • 6.2 China Phenazone (Antipyrine) Sales Volume and Sales Value, by Region

    Chapter 7 North China Phenazone (Antipyrine) Market Analysis

    • 7.1 North China Phenazone (Antipyrine) Market, by Type

    • 7.2 North China Phenazone (Antipyrine) Market, by Application

    Chapter 8 Central China Phenazone (Antipyrine) Market Analysis

    • 8.1 Central China Phenazone (Antipyrine) Market, by Type

    • 8.2 Central China Phenazone (Antipyrine) Market, by Application

    Chapter 9 South China Phenazone (Antipyrine) Market Analysis

    • 9.1 South China Phenazone (Antipyrine) Market, by Type

    • 9.2 South China Phenazone (Antipyrine) Market, by Application

    Chapter 10 East China Phenazone (Antipyrine) Market Analysis

    • 10.1 East China Phenazone (Antipyrine) Market, by Type

    • 10.2 East China Phenazone (Antipyrine) Market, by Application

    Chapter 11 Northeast China Phenazone (Antipyrine) Market Analysis

    • 11.1 Northeast China Phenazone (Antipyrine) Market, by Type

    • 11.2 Northeast China Phenazone (Antipyrine) Market, by Application

    Chapter 12 Southwest China Phenazone (Antipyrine) Market Analysis

    • 12.1 Southwest China Phenazone (Antipyrine) Market, by Type

    • 12.2 Southwest China Phenazone (Antipyrine) Market, by Application

    Chapter 13 Northwest China Phenazone (Antipyrine) Market Analysis

    • 13.1 Northwest China Phenazone (Antipyrine) Market, by Type

    • 13.2 Northwest China Phenazone (Antipyrine) Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)

        • 14.1.1 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Company Profile

        • 14.1.2 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Phenazone (Antipyrine) Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Guangdong Nanguo Pharmaceutical

        • 14.2.1 Guangdong Nanguo Pharmaceutical Company Profile

        • 14.2.2 Guangdong Nanguo Pharmaceutical Phenazone (Antipyrine) Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Henan Furen Huaiqingtang Pharmaceutical

        • 14.3.1 Henan Furen Huaiqingtang Pharmaceutical Company Profile

        • 14.3.2 Henan Furen Huaiqingtang Pharmaceutical Phenazone (Antipyrine) Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Bayer

        • 14.4.1 Bayer Company Profile

        • 14.4.2 Bayer Phenazone (Antipyrine) Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Shanxi Taiyuan Pharmaceutical

        • 14.5.1 Shanxi Taiyuan Pharmaceutical Company Profile

        • 14.5.2 Shanxi Taiyuan Pharmaceutical Phenazone (Antipyrine) Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Wuhan Fuxing Biopharmaceutical

        • 14.6.1 Wuhan Fuxing Biopharmaceutical Company Profile

        • 14.6.2 Wuhan Fuxing Biopharmaceutical Phenazone (Antipyrine) Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Hainan Pharmaceutical Factory

        • 14.7.1 Hainan Pharmaceutical Factory Company Profile

        • 14.7.2 Hainan Pharmaceutical Factory Phenazone (Antipyrine) Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Guangdong Sancai Shiqi District Pharmaceutical

        • 14.8.1 Guangdong Sancai Shiqi District Pharmaceutical Company Profile

        • 14.8.2 Guangdong Sancai Shiqi District Pharmaceutical Phenazone (Antipyrine) Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 CSPC

        • 14.9.1 CSPC Company Profile

        • 14.9.2 CSPC Phenazone (Antipyrine) Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Northeast Pharmaceutical

        • 14.10.1 Northeast Pharmaceutical Company Profile

        • 14.10.2 Northeast Pharmaceutical Phenazone (Antipyrine) Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Kaifeng Pharmaceutical Group

        • 14.11.1 Kaifeng Pharmaceutical Group Company Profile

        • 14.11.2 Kaifeng Pharmaceutical Group Phenazone (Antipyrine) Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 Shandong Fangming Pharmaceutical Group

        • 14.12.1 Shandong Fangming Pharmaceutical Group Company Profile

        • 14.12.2 Shandong Fangming Pharmaceutical Group Phenazone (Antipyrine) Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 NCPC

        • 14.13.1 NCPC Company Profile

        • 14.13.2 NCPC Phenazone (Antipyrine) Market Performance

        • 14.13.3 Product&Service Introduction

      • 14.14 Shandong Huaxin Pharmaceutical Group

        • 14.14.1 Shandong Huaxin Pharmaceutical Group Company Profile

        • 14.14.2 Shandong Huaxin Pharmaceutical Group Phenazone (Antipyrine) Market Performance

        • 14.14.3 Product&Service Introduction

      • 14.15 Pfizer

        • 14.15.1 Pfizer Company Profile

        • 14.15.2 Pfizer Phenazone (Antipyrine) Market Performance

        • 14.15.3 Product&Service Introduction

      • 14.16 Shandong Xinhua Pharmaceutical

        • 14.16.1 Shandong Xinhua Pharmaceutical Company Profile

        • 14.16.2 Shandong Xinhua Pharmaceutical Phenazone (Antipyrine) Market Performance

        • 14.16.3 Product&Service Introduction

      • 14.17 Yuekang Pharmaceutical Group Anhui Biopharmaceutical

        • 14.17.1 Yuekang Pharmaceutical Group Anhui Biopharmaceutical Company Profile

        • 14.17.2 Yuekang Pharmaceutical Group Anhui Biopharmaceutical Phenazone (Antipyrine) Market Performance

        • 14.17.3 Product&Service Introduction

      • 14.18 Endo

        • 14.18.1 Endo Company Profile

        • 14.18.2 Endo Phenazone (Antipyrine) Market Performance

        • 14.18.3 Product&Service Introduction

      • 14.19 Herbages Naturbec

        • 14.19.1 Herbages Naturbec Company Profile

        • 14.19.2 Herbages Naturbec Phenazone (Antipyrine) Market Performance

        • 14.19.3 Product&Service Introduction

      • 14.20 Sinopharm

        • 14.20.1 Sinopharm Company Profile

        • 14.20.2 Sinopharm Phenazone (Antipyrine) Market Performance

        • 14.20.3 Product&Service Introduction

      • 14.21 Henan Runhong Pharmaceutical

        • 14.21.1 Henan Runhong Pharmaceutical Company Profile

        • 14.21.2 Henan Runhong Pharmaceutical Phenazone (Antipyrine) Market Performance

        • 14.21.3 Product&Service Introduction

      • 14.22 Tianjin Jinyao Pharmaceutical

        • 14.22.1 Tianjin Jinyao Pharmaceutical Company Profile

        • 14.22.2 Tianjin Jinyao Pharmaceutical Phenazone (Antipyrine) Market Performance

        • 14.22.3 Product&Service Introduction

      • 14.23 Xinxiang Changle Pharmaceutical

        • 14.23.1 Xinxiang Changle Pharmaceutical Company Profile

        • 14.23.2 Xinxiang Changle Pharmaceutical Phenazone (Antipyrine) Market Performance

        • 14.23.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Phenazone (Antipyrine) Industry Research Conclusions

    • 15.2 Phenazone (Antipyrine) Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Phenazone (Antipyrine) Industry Market Size (2018-2029)

    • Figure China Phenazone (Antipyrine) Production Volume, Production Value and Growth Rate of Liquid (2018-2029)

    • Figure China Phenazone (Antipyrine) Production Volume, Production Value and Growth Rate of Solution (2018-2029)

    • Figure China Phenazone (Antipyrine) Sales Volume, Sales Value and Growth Rate of Analytical Reagent for Nitric Acid (2018-2029)

    • Figure China Phenazone (Antipyrine) Sales Volume, Sales Value and Growth Rate of Antipyretic And Analgesic (2018-2029)

    • Figure China Phenazone (Antipyrine) Sales Volume, Sales Value and Growth Rate of Nitrite and Iodine (2018-2029)

    • Figure North China Phenazone (Antipyrine) Market Size and Growth Rate from 2018-2029

    • Figure Central China Phenazone (Antipyrine) Market Size and Growth Rate from 2018-2029

    • Figure South China Phenazone (Antipyrine) Market Size and Growth Rate from 2018-2029

    • Figure East China Phenazone (Antipyrine) Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Phenazone (Antipyrine) Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Phenazone (Antipyrine) Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Phenazone (Antipyrine) Market Size and Growth Rate from 2018-2029

    • Figure Phenazone (Antipyrine) Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Phenazone (Antipyrine) Market Share by Type in 2018

    • Figure China Phenazone (Antipyrine) Market Share by Type in 2023

    • Figure China Phenazone (Antipyrine) Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Phenazone (Antipyrine) Production Volume and Growth Rate of Liquid (2018-2023)

    • Figure China Phenazone (Antipyrine) Production Volume and Growth Rate of Solution (2018-2023)

    • Figure China Phenazone (Antipyrine) Market Share by Application in 2018

    • Figure China Phenazone (Antipyrine) Market Share by Application in 2023

    • Figure China Phenazone (Antipyrine) Total Market Size and Growth Rate from Consumption End

    • Figure China Phenazone (Antipyrine) Market Size and Growth Rate of Analytical Reagent for Nitric Acid (2018-2023)

    • Figure China Phenazone (Antipyrine) Market Size and Growth Rate of Antipyretic And Analgesic (2018-2023)

    • Figure China Phenazone (Antipyrine) Market Size and Growth Rate of Nitrite and Iodine (2018-2023)

    • Table China Phenazone (Antipyrine) Production Volume by Region (2018-2023)

    • Table China Phenazone (Antipyrine) Production Volume Share by Region (2018-2023)

    • Figure China Phenazone (Antipyrine) Production Volume Share by Region (2018-2023)

    • Table China Phenazone (Antipyrine) Production Value by Region (2018-2023)

    • Table China Phenazone (Antipyrine) Production Value Share by Region (2018-2023)

    • Figure China Phenazone (Antipyrine) Production Value Share by Region (2018-2023)

    • Table China Phenazone (Antipyrine) Sales Volume by Region (2018-2023)

    • Table China Phenazone (Antipyrine) Sales Volume Share by Region (2018-2023)

    • Figure China Phenazone (Antipyrine) Sales Volume Share by Region (2018-2023)

    • Table China Phenazone (Antipyrine) Sales Value by Region (2018-2023)

    • Table China Phenazone (Antipyrine) Sales Value Share by Region (2018-2023)

    • Figure China Phenazone (Antipyrine) Sales Value Share by Region (2018-2023)

    • Table North China Phenazone (Antipyrine) Production Volume by Type (2018-2023)

    • Table North China Phenazone (Antipyrine) Production Volume Share by Type (2018-2023)

    • Figure North China Phenazone (Antipyrine) Production Volume Share by Type (2018-2023)

    • Table North China Phenazone (Antipyrine) Sales Volume by Application (2018-2023)

    • Table North China Phenazone (Antipyrine) Sales Volume Share by Application (2018-2023)

    • Figure North China Phenazone (Antipyrine) Sales Volume Share by Application (2018-2023)

    • Table Central China Phenazone (Antipyrine) Production Volume by Type (2018-2023)

    • Table Central China Phenazone (Antipyrine) Production Volume Share by Type (2018-2023)

    • Figure Central China Phenazone (Antipyrine) Production Volume Share by Type (2018-2023)

    • Table Central China Phenazone (Antipyrine) Sales Volume by Application (2018-2023)

    • Table Central China Phenazone (Antipyrine) Sales Volume Share by Application (2018-2023)

    • Figure Central China Phenazone (Antipyrine) Sales Volume Share by Application (2018-2023)

    • Table South China Phenazone (Antipyrine) Production Volume by Type (2018-2023)

    • Table South China Phenazone (Antipyrine) Production Volume Share by Type (2018-2023)

    • Figure South China Phenazone (Antipyrine) Production Volume Share by Type (2018-2023)

    • Table South China Phenazone (Antipyrine) Sales Volume by Application (2018-2023)

    • Table South China Phenazone (Antipyrine) Sales Volume Share by Application (2018-2023)

    • Figure South China Phenazone (Antipyrine) Sales Volume Share by Application (2018-2023)

    • Table East China Phenazone (Antipyrine) Production Volume by Type (2018-2023)

    • Table East China Phenazone (Antipyrine) Production Volume Share by Type (2018-2023)

    • Figure East China Phenazone (Antipyrine) Production Volume Share by Type (2018-2023)

    • Table East China Phenazone (Antipyrine) Sales Volume by Application (2018-2023)

    • Table East China Phenazone (Antipyrine) Sales Volume Share by Application (2018-2023)

    • Figure East China Phenazone (Antipyrine) Sales Volume Share by Application (2018-2023)

    • Table Northeast China Phenazone (Antipyrine) Production Volume by Type (2018-2023)

    • Table Northeast China Phenazone (Antipyrine) Production Volume Share by Type (2018-2023)

    • Figure Northeast China Phenazone (Antipyrine) Production Volume Share by Type (2018-2023)

    • Table Northeast China Phenazone (Antipyrine) Sales Volume by Application (2018-2023)

    • Table Northeast China Phenazone (Antipyrine) Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Phenazone (Antipyrine) Sales Volume Share by Application (2018-2023)

    • Table Southwest China Phenazone (Antipyrine) Production Volume by Type (2018-2023)

    • Table Southwest China Phenazone (Antipyrine) Production Volume Share by Type (2018-2023)

    • Figure Southwest China Phenazone (Antipyrine) Production Volume Share by Type (2018-2023)

    • Table Southwest China Phenazone (Antipyrine) Sales Volume by Application (2018-2023)

    • Table Southwest China Phenazone (Antipyrine) Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Phenazone (Antipyrine) Sales Volume Share by Application (2018-2023)

    • Table Northwest China Phenazone (Antipyrine) Production Volume by Type (2018-2023)

    • Table Northwest China Phenazone (Antipyrine) Production Volume Share by Type (2018-2023)

    • Figure Northwest China Phenazone (Antipyrine) Production Volume Share by Type (2018-2023)

    • Table Northwest China Phenazone (Antipyrine) Sales Volume by Application (2018-2023)

    • Table Northwest China Phenazone (Antipyrine) Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Phenazone (Antipyrine) Sales Volume Share by Application (2018-2023)

    • Table Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Company Profile

    • Table Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Phenazone (Antipyrine) Revenue, Price and Gross (2018-2023)

    • Table Guangdong Nanguo Pharmaceutical Company Profile

    • Table Guangdong Nanguo Pharmaceutical Phenazone (Antipyrine) Revenue, Price and Gross (2018-2023)

    • Table Henan Furen Huaiqingtang Pharmaceutical Company Profile

    • Table Henan Furen Huaiqingtang Pharmaceutical Phenazone (Antipyrine) Revenue, Price and Gross (2018-2023)

    • Table Bayer Company Profile

    • Table Bayer Phenazone (Antipyrine) Revenue, Price and Gross (2018-2023)

    • Table Shanxi Taiyuan Pharmaceutical Company Profile

    • Table Shanxi Taiyuan Pharmaceutical Phenazone (Antipyrine) Revenue, Price and Gross (2018-2023)

    • Table Wuhan Fuxing Biopharmaceutical Company Profile

    • Table Wuhan Fuxing Biopharmaceutical Phenazone (Antipyrine) Revenue, Price and Gross (2018-2023)

    • Table Hainan Pharmaceutical Factory Company Profile

    • Table Hainan Pharmaceutical Factory Phenazone (Antipyrine) Revenue, Price and Gross (2018-2023)

    • Table Guangdong Sancai Shiqi District Pharmaceutical Company Profile

    • Table Guangdong Sancai Shiqi District Pharmaceutical Phenazone (Antipyrine) Revenue, Price and Gross (2018-2023)

    • Table CSPC Company Profile

    • Table CSPC Phenazone (Antipyrine) Revenue, Price and Gross (2018-2023)

    • Table Northeast Pharmaceutical Company Profile

    • Table Northeast Pharmaceutical Phenazone (Antipyrine) Revenue, Price and Gross (2018-2023)

    • Table Kaifeng Pharmaceutical Group Company Profile

    • Table Kaifeng Pharmaceutical Group Phenazone (Antipyrine) Revenue, Price and Gross (2018-2023)

    • Table Shandong Fangming Pharmaceutical Group Company Profile

    • Table Shandong Fangming Pharmaceutical Group Phenazone (Antipyrine) Revenue, Price and Gross (2018-2023)

    • Table NCPC Company Profile

    • Table NCPC Phenazone (Antipyrine) Revenue, Price and Gross (2018-2023)

    • Table Shandong Huaxin Pharmaceutical Group Company Profile

    • Table Shandong Huaxin Pharmaceutical Group Phenazone (Antipyrine) Revenue, Price and Gross (2018-2023)

    • Table Pfizer Company Profile

    • Table Pfizer Phenazone (Antipyrine) Revenue, Price and Gross (2018-2023)

    • Table Shandong Xinhua Pharmaceutical Company Profile

    • Table Shandong Xinhua Pharmaceutical Phenazone (Antipyrine) Revenue, Price and Gross (2018-2023)

    • Table Yuekang Pharmaceutical Group Anhui Biopharmaceutical Company Profile

    • Table Yuekang Pharmaceutical Group Anhui Biopharmaceutical Phenazone (Antipyrine) Revenue, Price and Gross (2018-2023)

    • Table Endo Company Profile

    • Table Endo Phenazone (Antipyrine) Revenue, Price and Gross (2018-2023)

    • Table Herbages Naturbec Company Profile

    • Table Herbages Naturbec Phenazone (Antipyrine) Revenue, Price and Gross (2018-2023)

    • Table Sinopharm Company Profile

    • Table Sinopharm Phenazone (Antipyrine) Revenue, Price and Gross (2018-2023)

    • Table Henan Runhong Pharmaceutical Company Profile

    • Table Henan Runhong Pharmaceutical Phenazone (Antipyrine) Revenue, Price and Gross (2018-2023)

    • Table Tianjin Jinyao Pharmaceutical Company Profile

    • Table Tianjin Jinyao Pharmaceutical Phenazone (Antipyrine) Revenue, Price and Gross (2018-2023)

    • Table Xinxiang Changle Pharmaceutical Company Profile

    • Table Xinxiang Changle Pharmaceutical Phenazone (Antipyrine) Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.